104 results
Page 2 of 6
8-K
EX-10.1
iv5qc2p
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
zqzoli3i2d newif
10 Nov 21
Regulation FD Disclosure
7:12am
8-K
EX-10.1
j2tuwmr
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am
8-K
EX-99.1
8uhqvpn55yw38q1d1
17 May 21
Regulation FD Disclosure
5:03pm
8-K
EX-1.1
ajwq872ppko3llx7e
8 Apr 21
Entry into a Material Definitive Agreement
9:06am
424B5
bh8d0xd5
8 Apr 21
Prospectus supplement for primary offering
8:58am